Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage.

@article{Tam2005LongtermRO,
  title={Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage.},
  author={Wing Hung Tam and Michelle Hang Yuet Tsui and Ingrid Hung Lok and Shing Kai Yip and Pong Mo Yuen and Tony Kwok-Hung Chung},
  journal={Human reproduction},
  year={2005},
  volume={20 12},
  pages={
          3355-9
        }
}
BACKGROUND When compared with the conventional surgical evacuation for the treatment of miscarriage, medical evacuation has been largely accepted as an effective and safe management. However, there is a lack of data on the long-term reproductive outcome of these two treatment modalities, which is crucial in patient counselling. The current study evaluates and compares the long-term fertility and pregnancy outcome following these two treatments. METHODS A cohort of 604 women enrolled in a… 

Figures and Tables from this paper

Medical treatments for incomplete miscarriage (less than 24 weeks).

The available evidence suggests that medical treatment, with misoprostol, and expectant care are both acceptable alternatives to routine surgical evacuation given the availability of health service resources to support all three approaches.

Medical compared with surgical management in induced abortions and miscarriages

In Finland, medical abortion offered a good alternative to surgical method without increasing the risk of repeat abortions, but with an increased risk of short-term adverse events, and neither of the methods was economically superior in treating miscarriage.

Medical treatments for incomplete miscarriage.

The effectiveness, safety, and acceptability of any medical treatment for incomplete miscarriage (before 24 weeks), or alternative methods of medical treatment, with randomised controlled trials comparing medical treatment with expectant care or surgery, is assessed.

Medical and Surgical Treatment of First- trimester Silent Miscarriage: a Three-year Review

Both medical and surgical treatment had success rates comparable to published studies, and side-effects were significantly higher in those opting for medical treatment, while Nulliparous women had higher preference formedical treatment.

Outcomes of treatment for first trimester miscarriage

Although curettage is slightly more effective, expectant management is safe and also effective in at least 5 out of 6 women, quality of life did not differ between randomized women, and in the cohort, women who underwent Expectant management reported a slightly betterquality of life.

Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome.

Although this review does not allow strong clinical conclusions on treatment management, it signals an important clinical problem as the number of dilatation and curettage procedures seemed to be the main driver behind these associations.

Medical treatment for early fetal death (less than 24 weeks).

The effectiveness and safety of different medical treatments for the termination of non-viable pregnancies are assessed, from clinical trials, with a wide variety of different interventions which have been analysed across 23 different comparisons.

The effect of medical versus surgical treatment of spontaneous miscarriage on subsequent in vitro fertilization cycles

  • R. TamirSarit Allouche A. Wiser
  • Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2016
D&C and misoprostol are both effective treatments for IVF patients with miscarriage, without an adverse effect on subsequent IVF treatment outcome.

Methods for managing miscarriage: a network meta-analysis.

BACKGROUND Miscarriage, defined as the spontaneous loss of a pregnancy before 24 weeks' gestation, is common with approximately 25% of women experiencing a miscarriage in their lifetime. An estimated

References

SHOWING 1-10 OF 29 REFERENCES

Expectant management versus surgical evacuation in first trimester miscarriage: health-related quality of life in randomized and non-randomized patients.

Women with a miscarriage who chose their own treatment had the best health-related quality of life differences over time over time, supporting the role of free choice from a clinical point of view.

Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation.

A waiting period of 7 days after diagnosis may prevent 37% of surgical procedures, and intention-to-treat analysis including cross-overs showed similar effectiveness to that in the randomized groups.

Intrauterine adhesions after conservative and surgical management of spontaneous abortion.

Spontaneous Abortion: a Medical Approach to Management

It was found that no ERPC was necessary in the management of 118 out of 212 (55.6%) women who presented with spontaneous abortion, which has important implications in patient management and economical use of hospital resources.

Incomplete miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medical evacuation.

Vaginal misoprostol was as effective as oral misop frostol in medical uterine evacuation in patients with incomplete miscarriage and there was a reduction in the incidence of diarrhoea with the use of vaginal misopostol.

Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage

  • H. G. SahinH. SahinM. Koçer
  • Medicine
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2001
The use of misoprostol in the outpatient treatment of uncomplicated incomplete spontaneous miscarriage is safe and effective and can be an alternative to surgical evacuation and expectant management.

Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?

It is concluded that 200 mg of mifepristone and oral misoprostol is as effective and better tolerated than 600‬mg mifEPristone with oral misOProstol in the management of first trimester miscarriage.